Jun 02, 2020 / 01:00PM GMT
Rajbir Singh Denhoy - Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst
Thanks, everyone, again, for joining us here at the Jefferies 2020 Virtual Healthcare Conference. I'm Raj Denhoy with the medical device research team. Thanks, everyone, for joining us in these unprecedented times. Up next, we have TELA Bio. And from the company, we have Tony Koblish to tell us the story. So Tony, I'm going to turn over to you.
Antony Koblish - TELA Bio, Inc. - Co-founder, President, CEO & Director
Okay. Thank you, Raj, and good morning to everybody. I really appreciate your interest in the company, and I hope you guys are all doing well along with your families, as Raj said, in these crazy times.
First off, I'm going to acknowledge the safe harbor statement, and then we'll get into the presentation.
So TELA Bio is a soft tissue reconstruction company. We're a commercial stage organization. We've been commercial since the back half of 2016. We've done approximately 10,000 implantations across our product set.
TELA Bio Inc at Jefferies Healthcare Conference (Virtual) Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers